These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34535181)

  • 21.
    Zullo A; Perrotta G; D'Angelo R; Ruggiero L; Gravino E; Del Vecchio L; Santoro L; Salvatore F; Carsana A
    Biomed Res Int; 2019; 2019():7638946. PubMed ID: 31165076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RYR1 mutations are a common cause of congenital myopathies with central nuclei.
    Wilmshurst JM; Lillis S; Zhou H; Pillay K; Henderson H; Kress W; Müller CR; Ndondo A; Cloke V; Cullup T; Bertini E; Boennemann C; Straub V; Quinlivan R; Dowling JJ; Al-Sarraj S; Treves S; Abbs S; Manzur AY; Sewry CA; Muntoni F; Jungbluth H
    Ann Neurol; 2010 Nov; 68(5):717-26. PubMed ID: 20839240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy.
    Schartner V; Romero NB; Donkervoort S; Treves S; Munot P; Pierson TM; Dabaj I; Malfatti E; Zaharieva IT; Zorzato F; Abath Neto O; Brochier G; Lornage X; Eymard B; Taratuto AL; Böhm J; Gonorazky H; Ramos-Platt L; Feng L; Phadke R; Bharucha-Goebel DX; Sumner CJ; Bui MT; Lacene E; Beuvin M; Labasse C; Dondaine N; Schneider R; Thompson J; Boland A; Deleuze JF; Matthews E; Pakleza AN; Sewry CA; Biancalana V; Quijano-Roy S; Muntoni F; Fardeau M; Bönnemann CG; Laporte J
    Acta Neuropathol; 2017 Apr; 133(4):517-533. PubMed ID: 28012042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    Jungbluth H; Zhou H; Sewry CA; Robb S; Treves S; Bitoun M; Guicheney P; Buj-Bello A; Bönnemann C; Muntoni F
    Neuromuscul Disord; 2007 Apr; 17(4):338-45. PubMed ID: 17376685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene.
    Jungbluth H; Zhou H; Hartley L; Halliger-Keller B; Messina S; Longman C; Brockington M; Robb SA; Straub V; Voit T; Swash M; Ferreiro A; Bydder G; Sewry CA; Müller C; Muntoni F
    Neurology; 2005 Dec; 65(12):1930-5. PubMed ID: 16380615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Natural History of Pediatric Dominant and Recessive
    Sarkozy A; Sa M; Ridout D; Fernandez-Garcia MA; Distefano MG; Main M; Sheehan J; Manzur AY; Munot P; Robb S; Wraige E; Quinlivan R; Scoto M; Baranello G; Gowda V; Mein R; Phadke R; Jungbluth H; Muntoni F
    Neurology; 2023 Oct; 101(15):e1495-e1508. PubMed ID: 37643885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Functional Analysis of RYR1 Variants in a Family with a Suspected Myopathy and Associated Malignant Hyperthermia.
    Schiemann AH; Roesl C; Pollock N; Langton E; Bulger T; Stowell KM
    J Neuromuscul Dis; 2020; 7(1):51-60. PubMed ID: 31903994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel RYR1 variant in an infant with a unique fetal presentation of central core disease.
    Baker EK; Al Gharaibeh FN; Bove K; Calvo-Garcia MA; Shillington A; VandenHeuvel K; Cortezzo DE
    Am J Med Genet A; 2023 Jun; 191(6):1646-1651. PubMed ID: 36965156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes.
    Wehner M; Rueffert H; Koenig F; Meinecke CD; Olthoff D
    Cell Calcium; 2003 Aug; 34(2):163-8. PubMed ID: 12810058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked Facial Weakness, Ptosis, and Hanging Jaw: A Case with
    Singanamalla B; Kesavan S; Aggarwal D; Chatterjee D; Urtizberea A; Suthar R
    J Pediatr Genet; 2023 Dec; 12(4):318-324. PubMed ID: 38162159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant hyperthermia-associated mutations in the S2-S3 cytoplasmic loop of type 1 ryanodine receptor calcium channel impair calcium-dependent inactivation.
    Gomez AC; Holford TW; Yamaguchi N
    Am J Physiol Cell Physiol; 2016 Nov; 311(5):C749-C757. PubMed ID: 27558158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies.
    Zhou H; Jungbluth H; Sewry CA; Feng L; Bertini E; Bushby K; Straub V; Roper H; Rose MR; Brockington M; Kinali M; Manzur A; Robb S; Appleton R; Messina S; D'Amico A; Quinlivan R; Swash M; Müller CR; Brown S; Treves S; Muntoni F
    Brain; 2007 Aug; 130(Pt 8):2024-36. PubMed ID: 17483490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dominant or recessive mutations in the
    Galleni Leão L; Santos Souza L; Nogueira L; Pavanello RCM; Gurgel-Giannetti J; Reed UC; Oliveira ASB; Cuperman T; Cotta A; FPaim J; Zatz M; Vainzof M
    Acta Myol; 2020 Dec; 39(4):274-282. PubMed ID: 33458582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores.
    Jungbluth H; Müller CR; Halliger-Keller B; Brockington M; Brown SC; Feng L; Chattopadhyay A; Mercuri E; Manzur AY; Ferreiro A; Laing NG; Davis MR; Roper HP; Dubowitz V; Bydder G; Sewry CA; Muntoni F
    Neurology; 2002 Jul; 59(2):284-7. PubMed ID: 12136074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hot spot mutation screening of RYR1 gene in diagnosis of congenital myopathies].
    Chang XZ; Jin YW; Wang JM; Yuan Y; Xiong H; Wang S; Qin J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):691-7. PubMed ID: 25331388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unusual ryanodine receptor 1 (RYR1) phenotype: Mild calf-predominant myopathy.
    Jokela M; Tasca G; Vihola A; Mercuri E; Jonson PH; Lehtinen S; Välipakka S; Pane M; Donati M; Johari M; Savarese M; Huovinen S; Isohanni P; Palmio J; Hartikainen P; Udd B
    Neurology; 2019 Apr; 92(14):e1600-e1609. PubMed ID: 30842289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A central core disease mutation in the Ca
    Chirasani VR; Xu L; Addis HG; Pasek DA; Dokholyan NV; Meissner G; Yamaguchi N
    Am J Physiol Cell Physiol; 2019 Aug; 317(2):C358-C365. PubMed ID: 31166712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central core disease is due to RYR1 mutations in more than 90% of patients.
    Wu S; Ibarra MC; Malicdan MC; Murayama K; Ichihara Y; Kikuchi H; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Brain; 2006 Jun; 129(Pt 6):1470-80. PubMed ID: 16621918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial and sporadic forms of central core disease are associated with mutations in the C-terminal domain of the skeletal muscle ryanodine receptor.
    Monnier N; Romero NB; Lerale J; Landrieu P; Nivoche Y; Fardeau M; Lunardi J
    Hum Mol Genet; 2001 Oct; 10(22):2581-92. PubMed ID: 11709545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.